NLRP3 and COVID-19: It is primarily released by macrophages, monocytes, and dendritic cells.157 IL-1β derived is from inactive IL-1β precursors via NLRP3 inflammasome cleavage.158 Several studies suggested that IL-1β might contribute to the severity of COVID-19 symptoms and autoinflammatory diseases.159-161